Akash Parvatikar leads R&D for Histowiz's AI-powered digital pathology platforms, revolutionizing cancer diagnosis. His work ...
Delve Detect delivers 22 percent greater diagnostic yield with results the next day, offering an important new tool for managing complex central nervous system infections, including co-infection and ...
The United States and Canadian Academy of Pathology (USCAP) hosted its 108th annual meeting March 16-21, 2019, at the Gaylord National Resort & Convention Center in National Harbor, Maryland, where ...
Zacks Investment Research on MSN
How TEM is capitalizing on AI-driven pathology market growth
Investors are increasingly focused on the artificial intelligence (AI) in pathology market, which is expected to reach $1.15 billion by 2033, at a CAGR of 27.18% between 2025 and 2033 (per Grand View ...
Quantitative analysis of breast parenchymal background enhancement (BPE) on magnetic resonance (MR) imaging: Association with mammographic breast density and aggressiveness of the primary cancer in ...
Robot-Assisted PCI as a Strategy to Reduce the Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses Receive the the latest news, research, and presentations from major ...
Presentations at Association for Molecular Pathology 2025 Annual Meeting Spotlight Clinical Impact of Delve Bio’s Metagenomic Sequencing Test for Improving CNS Diagnosis Delve Detect delivers 22 ...
The MarketWatch News Department was not involved in the creation of this content. Delve Detect delivers 22 percent greater diagnostic yield with results the next day, offering an important new tool ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results